• 1952:
Insulin,
Charles H. Best, PMID 12979967 • 1954:
Hormones of the Pituitary Posterior Lobe,
Sir Henry Dale, PMID 14365538 • 1956:
Recent Advances in Insulin Research,
William C. Stadie, PMID 13356715 • 1957:
Certain Aspects of the Metabolism of Glycogen,
DeWitt Stetten Jr. PMID 13461755 • 1959:
The Adrenal and Diabetes: Some Interactions and Interrelations,
George W. Thorn,
Albert E. Renold,
George F. Cahill Jr. PMID 13838198 • 1960:
Childhood Diabetes: Its Course, and Influence on the Second and Third Generations,
Priscilla White, PMID 13784844 • 1961:
Concerning the Mechanisms of Insulin Action,
Rachmiel Levine, PMID 14464644 • 1963:
Hormonal Factors of Diabetic Ketosis,
Bernardo A. Houssay, PMID 14075320 • 1965:
Some Current Controversies in Diabetes Research,
Solomon A. Berson,
Rosalyn S. Yalow, PMID 5318828 • 1967:
Angiopathy in Diabetes: An Unsolved Problem,
Alexander Marble, PMID 4866594 • 1968:
Fifty Years of Diabetes in Perspective, Arthur R. Colwell Sr. PMID 4878652 • 1971:
Physiology of Insulin In Man,
George F. Cahill Jr. PMID 4941092 • 1973:
Islet Differentiation, Organ Culture, and Transplantation, Arnold Lazarow, Lemen J. Wells, Anna-Mary Carpenter, Orion D. Hegre, Robert J. Leonard, Robert C. McEvoy, PMID 4128246 • 1975:
Diabetes and the Alpha Cell,
Roger H. Unger, PMID 814024 • 1980:
Of Pregnancy and Progeny,
Norbert Freinkel, PMID 7002669 • 1981:
Macro- and Micro-Domains in the Endocrine Pancreas,
Lelio Orci PMID 6759269 • 1986:
Does a Common Mechanism Induce the Diverse Complications of Diabetes?, Albert I. Winegrad, PMID 3026877 • 1987: Insulin Signaling Mechanisms, Joseph Larner, https://diabetes.diabetesjournals.org/content/37/3/262.short • 1988:
Role of Insulin Resistance in Human Disease,
Gerald M. Reaven, and • 1989:
Structure and Function of Insulin Receptors,
Ora M. Rosen, PMID 2555239 • 1990:
β-Cells in Type II Diabetes Mellitus, Daniel Porte, Jr. • 1991:
Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis, C.N. Hales, • 1994:
Hypoglycemia: The Limiting Factor in the Management of IDDM, Philip E. Cryer, PMID 7926315 • 1995:
A Lesson in Metabolic Regulation Inspired by the Glucokinase Glucose Sensor Paradigm,
Franz M. Matschinsky, • 1997:
Control of Glucose Uptake and Release by the Liver In Vivo, Alan D. Cherrington, • 2001:
Dysregulation of Fatty Acid Metabolism in the Etiology of Type 2 Diabetes, J. Denis McGarry, PMID 11756317 • 2002 Samuel W. Cushman, PhD • 2003:
Autoimmune Diabetes and the Circle of Tolerance, Aldo A. Rossini, PMID 14747275 • 2004:
The Pathobiology of Diabetic Complications: A Unifying Mechanism, Michael Brownlee, • 2005:
Critical Conversations: Fat, Brain, and the Regulation of Energy Balance,
Jeffrey S. Flier * 2006a:
Cure, Optimal Care and Total Commitment: What if they happened tomorrow?, Robert A. Rizza [https://web.archive.org/web/20070927234218/http://professional.diabetes.org/presentations_details.aspx?session=1685 • 2006b:
Harmony and Discord in the Orchestration of Glucose Metabolism, Richard Bergman * 2009a:
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus, Ralph A. DeFronzo, [https://diabetesjournals.org/diabetes/article/58/4/773/117/From-the-Triumvirate-to-the-Ominous-Octet-A-New PMID 19336687 • 2009b:
An Unfinished Journey—Type 1 Diabetes—Molecular Pathogenesis to Prevention,
George S. Eisenbarth, PMID 20350969 • 2011:
Hyperinsulinemia: Cause or Consequence?, Barbara E. Corkey, PMID 22187369 • 2012:
Regulation of Adipogenesis: Toward New Therapeutics for Metabolic Disease,
Bruce M. Spiegelman, PMID 23704518 • 2014:
Deciphering Metabolic Messages From the Gut Drives Therapeutic Innovation,
Daniel J. Drucker, PMID 25614665 • 2015:
The Multifaceted Roles of Adipose Tissue—Therapeutic Targets for Diabetes and Beyond, Philipp E. Scherer, PMID 27222389 • 2016:
Adipose Tissue, Inter-Organ Communication, and the Path to Type 2 Diabetes, Barbara B. Kahn, MD, PMID 30573674 • 2017
Insulin Action Research and the Future of Diabetes Treatment, Domenico Accili, MD PMID 30135131 • 2018
Mechanisms of Insulin Resistance: Implications for Obesity, Lipodystrophy and Type 2 Diabetes Gerald I. Shulman, ADA • 2019
“Treasure Your Exceptions”—Studying Human Extreme Phenotypes to Illuminate Metabolic Health and Disease, Stephen P. O’Rahilly, PMID 33355307 • 2020
A Journey in Diabetes: From Clinical Physiology to Novel Therapeutics, Ele Ferrannini, PMID 33472943 • 2021
Treatment of Type 2 Diabetes and Obesity on the Basis of the Incretin System, Jens Juul Holst, PMID 34711671 • 2022
K-ATP Channels and the Metabolic Regulation of Insulin Secretion in Health and Disease Frances M. Ashcroft PMID 37815796 • 2023
Overcoming Obesity: The Discovery of Multi Receptor Drugs, Matthias Tschöp, MD ADA • 2024
The Science of Diabetes and a Life of Trials, Rury R. Holman PMID 39836885 • 2025
Revisiting the β-cell: The Key to the Type 2 Diabetes Puzzle, Steven E. Kahn ADA Meeting News == See also ==